In a closed-door meeting with clergy from the Diocese of Rome late last week, Pope Leo XIV clobbered his priests with a distinctly 21st-century request: to resist the “temptation to prepare homilies ...

Signal issues cause multiple delays and cancellations on at least 6 commuter rail lines The Blue Line also had a power problem resulting in shuttle use from Orient Heights to Wonderland, the MBTA says ...

The romance industry, always at the vanguard of technological change, is rapidly adapting to A.I. Not everyone is on board. By Alexandra Alter Last February, the writer Coral Hart launched an ...

Abstract: Due to the inherent complexity of modern polymer extrusion lines caused by nonlinear, dynamic behavior with numerous influential factors, disturbances lead to higher scrap rates and ...

NEW YORK CITY (PIX11) — The MTA is proposing schedule changes to multiple subway lines that could improve service for commuters, according to a staff report for Wednesday’s board meeting. The changes ...

This story was originally published by ProPublica, a nonprofit newsroom that investigates abuses of power. Sign up to receive our biggest stories as soon as they’re published. The Trump administration ...

A map of the immune cell landscape found in the bone marrow of patients with multiple myeloma could shed light on how the immune system interacts with cancerous plasma cells. It could also help ...

Higher levels of CD4-positive naïve T cells in patients receiving CAR T-cell therapy for multiple myeloma are associated with longer PFS, suggesting T-cell composition may serve as a biomarker to ...

It may be a surprise to learn that you can define names of cells in Microsoft Excel instead of using the letter and number combinations. This makes it friendlier to read and understand. For example, ...

Explore the transformative potential of bispecific antibodies in multiple myeloma, offering hope for improved patient outcomes and possible cures. In this episode, experts discuss how bispecific ...

Martin F. Dietrich, MD, PhD, discusses the use of the CDK4/6 inhibitor trilaciclib to address myelosuppression associated with chemotherapy in small cell lung cancer. Martin F. Dietrich, MD, PhD, ...